Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Conditions: Hematologic Malignancies; Nonmalignant Diseases; Immunodeficiencies; Hemoglobinopathies; Genetic Inborn Errors of Metabolism; Fanconi's Anemia; Thalassemia; Sickle Cell Disease Intervention: Sponsor: University of California, San Francisco Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Cancer & Oncology | Faconi Anemia | Genetics | Hematology | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Transplants